The basal forebrain provides cholinergic inputs to primary visual cortex (V1) that play a key modulatory role on visual function. While basal forebrain afferents terminate in the infragranular layers of V1, acetylcholine is delivered to more superficial layers through volume transmission. Nevertheless, direct synaptic contact in deep layers 5 and 6 may provide a more immediate effect on V1 modulation. Using helper viruses with cell type specific promoters to target retrograde infection of pseudotyped and genetically modified rabies virus evidence was found for direct synaptic input onto V1 inhibitory neurons. These inputs were similar in number to geniculocortical inputs and, therefore, considered robust. In contrast, while clear evidence for dorsal lateral geniculate nucleus input to V1 excitatory neurons was found, there was no evidence of direct synaptic input from the basal forebrain. These results suggest a direct and more immediate influence of the basal forebrain on local V1 inhibition.
, and by many others in rodent (i.e., Lysakowski, Standage, & Benevento, 1986; Sanderson, Dreher, & Gayer, 1991; Van Hooser & Nelson, 2006; Marshel, Kaye, Nauhaus, & Callaway, 2012; Cruz-Martín et al., 2014; Tohmi, Meguro, Tsukano, Hishida, & Shibuki, 2014; Roth et al., 2016; Seabrook et al., 2017; Zhou, Maire, Masterson, & Bickford, 2017; Zhou, Masterson, Damron, Guido, & Bickford, 2018) .
Another subcortical region, the basal forebrain, has also long been known to provide input to visual cortex ( Figure 1a ; Henderson, 1981; Tigges et al., 1982; Carey & Rieck, 1987; Dreher, Dehay, & Bullier, 1990) ; however, the functional contribution of this input is only starting to become understood (i.e., Goard & Dan, 2009; Newman, Gupta, Climer, Monaghan, & Hasselmo, 2012; Pinto et al., 2013) . The basal forebrain output to cortex is predominantly characterized as cholinergic (Henderson, 1981; Sarter, Hasselmo, Bruno, & Givens, 2005; Pinto et al., 2013) . Given the high density of cholinergic varicosities and receptors within V1 (Lysakowski, Wainer, Bruce, & Hersh, 1989; Mechawar, Cozzari, & Descarries, 2000; Wong & Kaas, 2008; Wong & Kaas, 2010; Disney & Reynolds, 2014) and the functional contribution of acetylcholine to receptive field tuning, attentional modulation, and plasticity in V1 (Sillito & Kemp, 1983; Bear & Singer, 1986; Roberts et al., 2005; Herrero et al., 2008; Newman et al., 2012; Avery, Dutt, & Krichmar, 2014) , the basal forebrain is particularly well-suited to influence V1 processing (Chubykin, Roach, Bear, & Shuler, 2013; Pinto et al., 2013) .
Acetylcholine from the basal forebrain is delivered to V1 across most cortical layers via diffuse extra-synaptic modulation known as 'volume transmission' (Descarries, Gisiger, & Steriade, 1997; Sarter et al., 2005) . This is reinforced by anatomical evidence showing acetylcholine receptors evenly distributed across layers 2-6 (Disney, Domakonda, & Aoki, 2006; Disney, & Reynolds, 2014 . In layers 2/3, 5, and 6, cholinergic receptors are found predominantly on inhibitory neurons leading to GABAergic mediated suppression (Disney et al., 2006; Disney, Aoki, & Hawken, 2007; Disney, Aoki, & Hawken, 2012; Disney, & Reynolds, 2014) . Furthermore, basal forebrain afferents terminate exclusively within infragranular layers 5 and 6 (Figure 1b ; Carey & Rieck, 1987; Rieck & Carey, 1984) . Therefore, unlike superficial cortical layers, the effect on neurons in layers 5 and 6 can be more immediate.
Based on the preponderance of cholinergic receptors being found on inhibitory neurons (Disney et al., 2006; Disney, & Reynolds, 2014) one might expect direct synaptic basal forebrain inputs to primarily contact inhibitory neurons. To determine this, we took advantage of our recently developed technique (Liu et al., 2013) , where a helper virus containing either a GAD1 or an aCamKII promoter is used to target a genetically modified rabies virus (Wickersham et al., 2007) for retrograde tracing of the direct inputs to either inhibitory or excitatory V1 neurons, respectively (Figure 2 ). In this way we are able to determine whether or not there is a difference in direct synaptic inputs of the basal forebrain to inhibitory and excitatory neurons.
| M A TER I A LS A N D M ETH OD S

| Surgical procedures
Eighteen adult C57BL/6 mice of both sexes were used following procedures approved by the University of California, Irvine Institutional Animal Care and Use Committee and the Institutional Biosafety Committee, and the guidelines of the National Institutes of Health were followed. Six mice were given 9 injections of the mCherry (mCh) and/or green fluorescent protein (GFP) versions of the glycoprotein-deleted rabies virus (DG-RV; Table 1 ). Twelve different mice were given injections of a helper virus (AAV-GAD1-YTB or LV-aCamKII-YTB; Table 2 ).
Anesthesia was induced and maintained with isoflurane throughout the procedure. Once anesthetized animals were placed in a stereotaxic head-holder and a craniotomy was performed over the caudal half of neocortex under sterile conditions. Glass pipettes with tips broken to approximately 20 mm were filled with virus and inserted through dura using a computer-controlled micro-positioner attached to a KOPF stereotaxic arm. Coordinates between 3.0 and 4.5 mm posterior from Bregma and 1.25-3.25 mm lateral to the midline were used. DG-RV injections were made at a depth of 500 mm and a volume of 0.3 ml. For AAV and LV helper viruses, 0.5 ml injections were made in a single V1 location at a cortical depth between 400 and 600 mm. After injection, artificial dura (Tecoflex, Microspec Corp.) was placed over the craniotomy, the skull sealed with dental acrylic, and the animals revived.
Mice injected with DG-RV were given a 7-10 days survival time and then perfused for histology.
Mice injected with helper virus were given a 3 week survival period followed by an intracranial injection of EnvA-DG-RV (see Figure   2 for injection timeline). For EnvA-DG-RV injections each animal was anesthetized as before, and under sterile conditions the acrylic skull cap removed and EnvA injections of 0.5 ml made as close as possible to the original helper virus injected location based on the coordinates and landmarks described above. The craniotomy was then covered with fresh Tecoflex, resealed with dental acrylic, and the animals revived. A final survival period ranging from 7 to 10 days followed.
| Viruses
The DG-RV expressing either mCherry or GFP, and the EnvA-DG-RV expressing mCherry were produced and concentrated following protocols described previously (Wickersham et al., 2007 , Wickersham, Sullivan, & Seung, 2010 Osakada, & Callaway, 2013 ) a titer range if of 5 3 10 9 infectious units/ml.
For helper viruses, GAD1-YTB (7,382 bp) and aCamKII-YTB (7,500 bp) were sublconed into adeno-associated virus (AAV) and lentiviral (LV) backbones to make AAV-GAD1-YTB (11.0 kb) and LV-aCamKII-YTB (12.3 kb), as described previously (Liu et al., 2013) . From these plasmids, serotype 9 AAV and VSV-G pseudotyped LV particles were prepared and purified by the Gene Transfer Targeting and Therapeutics
Core at the Salk Institute of Biological Studies (La Jolla, CA) yielding a titer of 9 3 10 9 genome copies/ml for AAV and 2 3 10 10 transducing units/ml for LV.
| Histology and antibody reporting
For histology, animals were deeply anesthetized with Euthasol and perfused transcardially, first with saline, then followed by 4% paraformaldehyde in phosphate buffer (PB; pH 7.4). For most animals, 1.5%
glutaraldehyde was also included. Brains were removed and cryoprotected in 30% sucrose for 48 hr prior to sectioning.
Brains were cut coronally at 30 mm up to 1 mm posterior and anterior to the V1 injection site, and at 40 mm elsewhere. A series of every fourth 30 mm section was processed for GABA using the anti-GABA rabbit polyclonal antibody (1:200; Sigma-Aldrich Cat# A2052, RRID:
AB_477652; tested in GABA expressing cells isolated from the pallium in mice; conjugated to BSA). Immunopositive neurons were revealed using the fluorescent secondary Alexa Fluor 350 goat anti-rabbit IgG
(1:500; Invitrogen). To enhance visualization of yellow fluorescent protein (YFP) the same sections were also processed for the anti-GFP chicken polyclonal antibody (1:1,000; Novus Cat# NB 100-1614, RRID:AB_523902; tested on transgenic mice expressing recombinant GFP; Immunogen affinity purified) and revealed using Alexa Fluor 488 goat anti-rabbit IgG (1:500; Invitrogen). The mCherry and GFP reporters from rabies virus were not enhanced through immunofluorescence.
One to two additional series of every fourth section were processed instead for DAPI. Rabies virus infected neurons could be visualized in all sections without processing. Sections were mounted in PVA-DABCO (Sigma-Aldrich) to preserve fluorescence.
| Data analysis
Sections were examined using fluorescent microscopy (Zeiss Axioplan) 
| R E SU LTS
Using injections of cell type specific viral tracers in V1, we found that neurons in the basal forebrain project directly to V1 inhibitory neurons, but found no evidence for direct projections to cortical excitatory neurons. We also found the basal cortical projections to be similar in number to LGN inputs to V1.
| DG-RV retrograde infection of basal forebrain
Prior to using the cell type specific helper viruses to target EnvA-DG-RV, we first made injections of DG-RV. The DG-RV version of rabies virus acts as a monosynaptic retrograde tracer and does not require a helper virus (Wickersham et al., 2007; Connolly, Hashemi-Nezhad, & Lyon, 2012) . While this virus cannot distinguish between inputs to inhibitory and excitatory neurons, the goal of these injections was to determine the ability and degree to which rabies virus infects basal forebrain neurons targeting V1 by comparing to the number of infected neurons in the LGN.
Nine distinct injections of DG-RV with either the mCherry or GFP reporter were made into V1 of 6 mice ( Table 1 ). All 9 injections resulted in labeled neurons in the diagonal band of the basal forebrain and the
LGN, with the average for basal forebrain (13.4 6 4.9) about two thirds that of the number of neurons found in the LGN (21.3 6 6.5).
An example of two injections in the same animal is shown in Figure 3a. Based on the density of intrinsic V1 labeled neurons, the injection sites reached layers 4, 5, and 6 which would be necessary to target axon terminals from LGN and basal forebrain neurons. A reconstruction of the pattern of labeled cells from an injection in a second case is shown in Figure 4a . As in the digital image in Figure   3a , LGN neurons were packed together more tightly with smaller somas and shorter dendrites (Figure 4b ).
| AAV-GAD1-YTB targeted retrograde tracing with EnvA-DG-RV
To determine whether basal forebrain neurons project to V1 inhibitory neurons we made injections of the helper virus, AAV-GAD1-YTB, to target infection of the retrograde EnvA-DG-RV to inhibitory neurons.
Injections were made into a single V1 hemisphere of 6 mice ( Table 2 ).
In five of six cases, retrograde infected neurons were found in the diag- (Table 2 ).
| LV-aCamKII-YTB targeted retrograde tracing with EnvA-DG-RV
To determine whether basal forebrain neurons project to V1 excitatory neurons we made injections of the lentiviral vector, LV-aCamKII-YTB, to target infection of the retrograde EnvA-DG-RV to excitatory
neurons. Injections were made into a single V1 hemisphere of 6 mice (Table 2 ). In five of six cases (Table 2) , retrograde infected neurons were found in the LGN (6.4 6 1.7 per case). However, no infected neurons were found in the basal forebrain.
An injection site example is shown from one case in Figure 3i were defined as neurons co-expressing YFP and mCherry (yellow neurons in Figure 3j ); Neurons expressing mCherry only were defined as presynaptically connected neurons. Yellow starter cells were evident throughout layers 4, 5, and 6 (Figure 3i ; see also Table 2 ).
A reconstruction of the distribution of inputs to V1 excitatory starter cells is shown in a second case (Figure 6a ). In the posterior most section, starter cells were distributed throughout layers 4, 5 and 6, with presynaptically connected neurons found in the LGN in section 70 (Figure 6b ).
Presynaptically infected neurons were labeled as far posterior as the cingulate cortex (Cg), but no cells were found in the basal forebrain.
| D I SCUSSION
The goal of this present experiment was to determine the cell type specific nature of projections from the basal forebrain to primary visual cortex. Using a dual viral retrograde tracing method we found evidence for direct synaptic input to inhibitory neurons ( Figure 7 ). These inputs were robust as they were similar in number to geniculocortical inputs to inhibitory neurons (Table 2 ). In contrast, we found clear evidence for
LGN input to V1 excitatory neurons, but no evidence for direct synaptic input from the basal forebrain ( Figure 7) . Taken into consideration with other evidence discussed below, our results indicate a strong direct influence of the basal forebrain on local V1 inhibition.
We previously demonstrated the cell type specificity of AAV-GAD1 and LV-aCamKII on cortical inhibitory and excitatory neurons, and showed that the delivery of YTB through these helper viruses was sufficient to label presynaptic inputs throughout the brain, with an emphasis on intrinsic V1 connectivity (Liu et al., 2013 ). Here we reconfirmed the cell type specificity of each helper virus and found differences in the basal forebrain inputs to V1.
The observed projection of basal forebrain to inhibitory, but not excitatory V1 neurons was not likely due to differences in the two helper viruses used. On the contrary, viral vectors were optimized for their endogenous neurotropism; lentivirus for excitatory neurons and low-titer AAV for inhibitory neurons (Nathanson, Yanagawa, Obata, & Callaway, 2009 ). Moreover, both helper viruses resulted in retrogradely infected neurons in the LGN; the LGN provided input to both inhibitory and excitatory V1 neurons. Demonstrating that the AAV and lentiviral vectors were both effective at initiating cell type specific retrograde tracing of EnvA-DG-RV.
Because previous reports found that only deep V1 injections provided retrograde labeling of basal forebrain neurons (Carey & Rieck, 1987; Rieck & Carey, 1984) , we also targeted infragranular layers with our viruses. No discernable difference was found between the distribution of inhibitory and excitatory starter cells in layers 5 and 6.
While no basal forebrain neurons were found to project to excitatory V1 cells. This does not necessarily mean that this connection is not present. Our method of complementation of EnvA-DG-RV with the B19 strain of the rabies glycoprotein (B from YTB) is most likely to label stronger connections, based on the number of synaptic inputs (Liu Tables 1 and 2 ). In addition, studies using transgenic mice to provide higher levels of the rabies glycoprotein did show a basal forebrain input to three types of V1 excitatory neurons (Kim, Jacobs, Ito-Cole, & Callaway, 2016) .
A stronger or exclusive direct synaptic input to infragranular inhibitory neurons as our results suggest, is consistent with other work indicating a greater effect of the cholinergic system on inhibition in V1.
While an excitatory effect of acetylcholine has been observed, this is likely most predominant in layer 4 where there is an abundance of nicotinic receptors found on excitatory neurons (Disney et al., 2007) .
However, in layers 2/3, 5, and 6, M1 and M2 type muscarinic receptors are found predominantly on inhibitory neurons, despite inhibitory neurons only representing 20% of the V1 neural population (Disney et al., 2006 (Disney et al., , 2007 (Disney et al., , 2012 . Consistent with this anatomy, in layers 2/3, 5, and 6, acetylcholine largely leads to suppressed V1 cell activity (Disney et al., 2012) . Moreover, in layer 5 acetylcholine release was shown to amplify the inhibitory signal and decreases the excitability and sensory responsiveness of pyramidal neurons (Lucas-Meunier et al., 2009 ).
This inhibitory effect could result from direct synaptic contact onto local deep layer inhibitory neurons, which in turn suppress neighboring excitatory pyramidal cells.
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